John Puisis
Advertisement
John Puisis is a consultant with Spencer Stuart, an investment advisor specializing in biotech and pharmaceutical companies, based in Chicago.
Articles by John Puisis
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Sends Refusal-to-File Letter to Moderna for Seasonal Influenza Vaccine, Enters Long-Term Agreement with Government of Mexico
2
Today’s China Crucible: What It Means for Pharma
3
FDA Approves Keytruda-Based Regimen for PD-L1–Positive Platinum-Resistant Ovarian Cancer
4
Eli Lilly Enters $8.5 Billion Strategic Collaboration with Innovent Biologics and Acquires Orna Therapeutics
5
